FDA recently approved changes to the EPIVIR (lamivudine) package insert.
The approved changes are detailed here.
FDA approves changes to the Epivir label
01/10/2017
EATG » FDA approves changes to the Epivir label
Newsletter / News bulletin
Latest news
New UNAIDS report shows backsliding and broken promises in the global AIDS response
Eshowe, South Africa, July 16, 2019 — UNAIDS released new data regarding the state of the global AIDS response today, showing that the global target of reducing both new HIV…
Read moreUniversal test and treat won’t stop HIV epidemic
Universal test-and-treat strategies resulted in "modest to no reductions" in new HIV transmissions in three large population-based studies, writes Salim Abdool-Karim, MD, ChB, PhD, of the Centre for the AIDS Programme of…
Read moreThe new face of HIV and treating the ‘hardly reached’
MEXICO CITY — For Wendy Armstrong, MD, who still sees patients die from complications of AIDS, news of monthly injectable HIV treatment, simplified regimens, and better tolerated antiretroviral drugs are exciting. But…
Read moreLatest projects
EFOEUPATI – Ensuring the future of EUPATI beyond 2020
Project aims: To ensure the sustainability of the results of the EUPATI project, to develop sustainable models of collaboration to ensure this, and put into place the infrastructure required for…
PARADIGM – Patients Active in Research and Dialogues for an Improved Generation of Medicines
Project aims: To provide a framework that allows structured, meaningful, sustainable and ethical patient engagement throughout three key decision-making points of the development of medicinal products: (i) the research priority…
HIV Outcomes – Beyond Viral Suppression
Initiative aims: HIV Outcomes, is a multi-stakeholder initiative developing and communicating expert, evidence based consensus recommendations for policy makers focused on the provision and delivery of high quality of care…
